Redsense Medical has signed an agreement with Ann-Marie Eriksson, who will be the Company's new Chief Technology Officer. When Ann-Marie joins the Company, she will be responsible for leading the R&D projects, a key task as the Company continues to develop its blood loss detection technology into a comprehensive solution for smart wound care adapted to meet thedemands of the future. As the new CTO, she will also be responsible for managing the Company's regulatory work relating to quality systems, and for securing input to the Company's supply chain - a critical area, especially in view of the Company's expansion strategy to intensify and accelerate sales, with a particular focus on the rapidly growing US market, and to strengthen the supply chain to handle larger volumes. Ann-Marie Eriksson most recent position was at the Halmstad branch of Etteplan Sweden AB.